GlassScriptPhysician profile
Matthew William Gordon
NPI 1003266032
$3,460.93
in general payments reported to CMS, 2019-2025
21 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $962 · 2021: $779 · 2022: $291 · 2023: $338 · 2024: $503 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $953.78 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $772.37 | 2019-2025 | Farxiga, Saphnelo |
| Amarin Pharma, INC. | $472.59 | 2019-2021 | |
| Amgen INC. | $374.00 | 2019-2025 | Otezla, Otezla, Repatha |
| Pfizer INC. | $208.07 | 2019-2024 | |
| Novo Nordisk INC | $157.43 | 2021 | |
| Lilly USA, LLC | $98.81 | 2021-2024 | Jardiance |
| Glaxosmithkline, LLC. | $58.81 | 2024-2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.86 | 2021-2022 | |
| Horizon Therapeutics Plc | $40.58 | 2023 | Krystexxa |
| Biohaven Pharmaceutical Holding Company LTD. | $36.18 | 2022 | |
| Exact Sciences Corporation | $35.84 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $33.13 | 2020 | |
| Janssen Biotech, INC. | $24.67 | 2025 | Tremfya |
| Biohaven Pharmaceuticals, INC. | $23.48 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $23.20 | 2022 | |
| Merck Sharp & Dohme LLC | $20.00 | 2023 | Gardasil 9 |
| Tactile Systems Technology INC | $19.38 | 2020 | |
| Corcept Therapeutics | $18.47 | 2023 | Korlym |
| Mannkind Corporation | $17.13 | 2019 | |
| Allergan, INC. | $15.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.